Ann: Opthea Phase 2b wAMD trial fully recruited ahead of schedule, page-4

Hi Whytee, While I support many of the views expressed in your posts this is one I beg to differ on. I cannot agree with your comment “Just goes shows you need to be discerning”. When it comes to investing in biotech it is not just mum and dad retail investors who get caught out, some so called very smart institutional investors have also been badly burnt by biotech.
Seriously I don’t think there would be one long term investor in Australian biotech who has not had a biotech investment failure in their portfolio.......and I have had several, so yes I definitely have sympathy for those who lose money. If it was all so straight forward and there was no risk we’d all be rich.